News from NIAID-Supported Institutions

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Genetic Signature Identified for RSV, the Leading Cause of Infant Hospitalizations Worldwide 
November 14, 2013—The Research Institute at Nationwide Children’s Hospital

Gut Microbes in Healthy Kids Carry Antibiotic Resistance Genes 
November 13, 2013—Washington University School of Medicine

Researchers Discover New Treatment to Cure the MRSA ‘Superbug’ 
November 13, 2013—Northeastern University

Putting Lupus in Permanent Remission   
November 11, 2013—Northwestern Medicine

Discovery by Israeli and American Researchers May Lead to New Treatments for Allergic Diseases 
November 10, 2013—Cincinnati Children’s Hospital Medical Center

Agenus’ HerpV Therapeutic Vaccine for Genital Herpes Meets Primary Endpoint in Randomized Phase 2 Trial 
November 7, 2013—Agenus Inc.

Study Uncovers New Explanation for Infection Susceptibility in Newborns 
November 6, 2013—Cincinnati Children’s Hospital Medical Center

Roswell Park Researchers Receive Almost $7 Million in Grant Support for Cancer Research Efforts 
November 5, 2013—Roswell Park Cancer Institute

University of Washington Awarded New NIH Contract to Advance Research on Milestone Development of Vaccine Immune Boosters 
November 4, 2013—Kineta, Inc.

Penn Researchers Identify Molecular Link Between Gut Microbes and Intestinal Health 
November 4, 2013—Perelman School of Medicine

Leidos Awarded Contract by National Institutes of Health 
November 4, 2013—Leidos

Multimillion Dollar Contract Provides Funding to Continue Vaccine Research 
November 1, 2013—Baylor College of Medicine

Examining How Cytomegalovirus Spreads from Mother to Fetus 
November 1, 2013—University of Massachusetts Medical School

Children of Lower Socioeconomic Status Grow Up More Susceptible To Catching Colds, Carnegie Mellon Researchers Find 
November 1, 2013—Carnegie Mellon University

Newly Identified Proteins Make Promising Targets for Blocking Graft-vs.-Host Disease 
October 31, 2013—University of Michigan Health System 

Transgene in Collaboration with Emergent BioSolutions to Receive NIH Funding to Support Development of a Novel Immunotherapy Against Tuberculosis 
October 30, 2013—Transgene SA

Dormant Reservoirs of HIV Hiding Inside Infected Cells Represent Our Biggest Barrier to Eradicating HIV/AIDS 
October 30, 2013—Gladstone Institutes

Early HIV Antiviral Treatment Found to Be Cost-Effective in South Africa, India 
October 30, 2013—Massachusetts General Hospital

Latest Research Findings on Avian Influenza A (H7N9) Virus from HKU Public Health Research Centre 
October 30, 2013—The University of Hong Kong

New SARS-Like Coronavirus Discovered in Chinese Horseshoe Bats 
October 30, 2013—EcoHealth Alliance

NanoBio Awarded up to $10 Million in NIH Funding to Develop a Pandemic Influenza Vaccine 
October 29, 2013—NanoBio Corporation

Pregnant Women with Hepatitis C May Pass Swifter Viral Strain to Newborns, Study Suggests 
October 28, 2013—Nationwide Children’s Hospital

Model Virus Structure Shows Why There’s no Cure for Common Cold 
October 28, 2013—University of Wisconsin—Madison

U of M Researchers Identify Key Proteins Influencing Major Immune Strategies  
October 28, 2013—University of Minnesota

More Opportunities Found for Respiratory Infections to Spread Among Staff in Emergency Departments 
October 23, 2013—Emory University

New Study Shows How Staph Toxin Disarms the Immune System, Reveals Secret to Microbe’s Deadly Versatility 
October 16, 2013—NYU Langone Medical Center

These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”